Showing 21 - 40 results of 65 for search '"Biological patents in the United States', query time: 3.07s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25

    Biosimilars in Oncology: Latest Trends and Regulatory Status by Deeksha Joshi, Rubiya Khursheed, Saurabh Gupta, Diksha Wadhwa, Thakur Gurjeet Singh, Sumit Sharma, Sejal Porwal, Swati Gauniyal, Sukriti Vishwas, Sanjay Goyal, Gaurav Gupta, Rajaraman D. Eri, Kylie A. Williams, Kamal Dua, Sachin Kumar Singh

    Published 2022-12-01
    “…Many countries, including the United States of America (USA), Canada, and Japan, have adopted Europe’s worldwide regulatory framework. …”
    Get full text
    Article
  6. 26
  7. 27

    Questões relevantes para a aprovação de medicamentos biossimilares Relevant issues to biossimilars licensing by Beatriz Serrapio Peres, Gabriela Padilha, Cristiane Quental

    Published 2012-12-01
    “…Based on the laws and guidelines studied, it is concluded that, although Brazil, Europe and the United States are at different stages of setting their regulatory framework for biossimilars, it is possible to identify some similarities in approach, such as the need for different treatment for each product class (or a case by case focus) and a step by step comparison exercise, the results of which will define the amount of data and non-clinical and clinical studies required. …”
    Get full text
    Article
  8. 28

    An overview of biosimilars for cancer, diabetes mellitus, rheumatoid arthritis and other immune-mediated diseases approved between 2016 and 2021 by Sivakumar Priyarega, Ramanathan Natarajan

    Published 2022-01-01
    “…The steep rise in the cost of brand name biologics and expiration of their patents led to the arrival of several new biosimilars in the United States (US) and European Union (EU) markets. …”
    Get full text
    Article
  9. 29
  10. 30

    Clay and Polymer-Based Composites Applied to Drug Release: A Scientific and Technological Prospection by Lyghia Maria Araújo Meirelles, Fernanda Nervo Raffin

    Published 2017-05-01
    “…The technological prospection encompassed the United States Patent and Trademark Office, the European Patent Office, the World International Patent Office and the National Institute of Industrial Property databases, filtering patents with the code A61K. …”
    Get full text
    Article
  11. 31
  12. 32
  13. 33
  14. 34
  15. 35

    A Systematic Review of Syngas Bioconversion to Value-Added Products from 2012 to 2022 by Marta Pacheco, Patrícia Moura, Carla Silva

    Published 2023-04-01
    “…Most of the published research was initially funded and developed in the United States of America. However, over the years, European countries have become the major contributors to syngas fermentation research, followed by China. …”
    Get full text
    Article
  16. 36
  17. 37

    Self-Tracking Pills by Mike Reaves

    Published 2016-03-01
    “…Proteus Biomedical, Inc., assignee. United States Patent #8114021. February 14, 2012.http://patents.justia.com/patent/8114021 [4] Stuart, Hunter. …”
    Get full text
    Article
  18. 38

    Self-Tracking Pills by Mike Reaves

    Published 2015-11-01
    “…Proteus Biomedical, Inc., assignee. United States Patent #8114021. February 14, 2012. http://patents.justia.com/patent/8114021 [4] Stuart, Hunter. …”
    Get full text
    Article
  19. 39
  20. 40